CUSTOM RECOMBINANT PROTEIN PRODUCTION SERVICES MARKET ANALYSIS

Regional Analysis

Global Custom Recombinant Protein Production Services Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global custom recombinant protein production services market over the forecast period. North America is estimated to hold 33.5% of the market share in 2023. The increasing adoption of inorganic strategies such as acquisitions and partnerships for the development of recombinant proteins by the key players in the market is expected to act as an opportunity for market growth over the forecast period. For instance, in August 2022, Orthofix US LLC, a medical device company, announced a strategic partnership agreement with CGbio, a developer of innovative, synthetic bone grafts for spine, orthopedic, trauma, and dental applications. As a part of this agreement, the two companies will work together for the clinical development and commercialization of Novosis recombinant human bone morphogenetic protein-2 (rhBMP-2) bone growth materials and other future tissue regenerative solutions for the Canadian and U.S. markets.

Geographies covered:

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa